Drug Profile
Research programme: cannabinoid extract therapeutics - Easton Pharmaceuticals
Alternative Names: Medicinal marijuana - Easton PharmaceuticalsLatest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator Easton Pharmaceuticals
- Class Cannabinoids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for research development in Undefined in USA (Transdermal, Patch)
- 28 Mar 2014 Easton Pharmaceuticals and a undisclosed company agree to co-develop cannabinoid extract therapeutics in USA
- 25 Mar 2014 Early research in Undefined indication in USA (Transdermal)